Vaccine development against infection with Helicobacter pylori

British Medical Bulletin

Volumn 54, Issue 1, 1998, Pages 229-241

  Kleanthous, Harry ^a   Lee, Cynthia K ^a   Monath, Thomas P ^a  

^a Acambis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; BACTERIAL PROTEIN; BACTERIAL VACCINE; RECOMBINANT PROTEIN; UREASE;

ANIMAL EXPERIMENT; BACTERIAL GENE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GASTRITIS; GENE SEQUENCE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; META ANALYSIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH ADENOCARCINOMA;

EID: 0031881388     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011673     Document Type: Review

References (37)

1. Lee CK, Soike K, Tibbitts T et al. Urease immunization protects against reinfection by Helicobacter pylori in rhesus monkeys. Gut 1996; 39 (Suppl 2): A45
2. Gilman RH, Leon-Barua R, Ramirez-Ramos A, Recavarren-Arce S, Watanabe J. Rapid recurrence of Helicobacter pylori infection in Peruvian patients after eradication therapy. Proc Clin Infect Dis J 1997; In press
3. Oderda G, Vaira D, Ainley C. Eighteen month follow-up of H. pylori positive children treated with amoxicillin and tinidazole. Dig Dis Sci 1992; 36: 572-6
4. Blaser MJ, Perez-Perez G, Kleanthous H et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 1-5
5. Pallen MJ, Clayton CL. Vaccination against Helicobacter pylori urease. Lancet 1990; 336: 186-7
6. Czinn SJ, Nedrud JG. Oral immunization against Helicobacter pylori. Infect Immun 1991; 59: 2359-63
7. Chen M, Lee A Vaccination possibilities and probabilities. In: Northfield TC, Mandell M, Goggin PM (Eds) Helicobacter pylori infection. Dordrecht: Kluwer, 1993; 158-69
8. Chen M, Lee A, Hazell S. Immunisation against gastric Helicobacter infection in a mouse Helicobacter felis model. Lancet 1992; 339: 1120-1
9. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993; 11: 637-42
10. Blanchard TG, Czinn SJ, Maurer R, Thomas W, Soman G, Nedrud JG. Urease specific monoclonal antibodies prevent Helicobacter felis infection in mice. Infect Immun 1995; 63: 1394-9
11. Michetti P, Couthésy-Theulaz I, Davin C et al. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994; 107: 1002-11
12. Lee CK, Weltzin RA, Thomas Jr WD et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995; 172: 161-72
13. Pappo J, Thomas Jr WD, Kabok Z, Taylor NS, Murphy JC, Fox JG. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect Immun 1995; 63: 1246-52
14. Ferrero RL, Thiberge JM, Huerre M, Labigne A. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect Immun 1994; 62: 4981-9
15. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-8
16. Kleanthous H, Tibbits T, Bakios TJ et al. In vivo selection of a highly adapted H. pylori isolate and the development of an H. pylori mouse model for studying vaccine efficacy. Gut 1995; 37: A94
17. Kleanthous H, Myers G, Georgokopoulos K et al. Effect of route of mucosal immunization with recombinant urease on gastric immune responses and protection against Helicobacter pylori infection. Gut 1996; 39 (Suppl 2): A75
18. Thomas JE, Austin S, Dale A et al. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet 1993; 342: 121
19. Doidge C, Gust I, Lee A, Buck F, Hazell S, Manne U. Therapeutic immunization against Helicobacter infection. Lancet 1994; 343: 914-5
20. Corthésy-Theulaz I, Porta N, Glauser M et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 1995; 109: 115-21
21. Cuenca R, Blanchard TG, Czinn SJ et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 1996; 110: 1770-5
22. Weltzin R, Kleanthous H, Guirakhoo F, Monath TP, Lee CK. Novel intranasal immunization techniques tor antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine 1997; 15: 370-6
23. Myers G, Ermak TH, Georgokopoulos K et al. Oral immunization with recombinant urease confers long-lasting immunity. Gut 1996; 39 (Suppl 2): A44
24. Atherton JC, Tham KT, Peek Jr RM, Cover TL, Blaser MJ. Density of Helicobacter pylori infection as assessed by quantitative culture and histology. J Infect Dis 1996; 174: 552-6
25. Ferrero RL, Thiberge JM, Kansau I, Wuchser N, Huerra M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995; 92: 6499-503
26. Kolesnikow T, Radcliff FJ, Hazell SL, Doidge C, Lee A. Helicobacter pylori catalase: a novel antigen for vaccination. Gut 1996; 39 (Suppl 2): A46
27. Appelmelk BJ, Simoons-Smit I, Negrini R et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 1996; 64: 2031-40
28. Ermak TH, Ding R, Ekstein B et al. Oral immunization of mice with recombinant Helicobacter pylori urease: corpus gastritis after challenge with H. felis is due to the presence of residual bacteria. Gastroenterology 1997; In press
29. Mohammedi M, Czinn S, Redline R, Nedrud J. Adoptive transfer of Helicobacter-specific Th1 or Th2 cells exacerbates Helicobacter-associated gastritis, but only Th2 cells reduce the magnitude of infection. Gut 1996; 39 (Suppl 2): A45
30. Fox JG, Batchelder M, Marini R et al. Helicobacter pylori-induced gastritis in the domestic cat. Infect Immun 1995; 63: 2674-81
31. Batchelder M, Fox JG, Monath T et al. Oral vaccination with recombinant urease reduces Helicobacter pylori colonization in the cat. Gastroenterology 1996; 110: A58
32. National Institutes of Health, Consensus Development Conference Statement: Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9
33. Mégraud F, Helicobacter pylori resistance to antibiotics. In: Hunt RH, Tytgat GNJ (Eds) Helicobacter pylori: basic mechanisms to clinical cure. Dordrecht: Kluwer, 1994; 570-83
34. Kleanthous H, Ermak T, Pappo J, Lee C, Monath T. Oral immunization with recombinant Helicobacter pylori urease apoenzyme in the treatment of Helicobacter infection. Gut 1995 37: A94
35. Kleanthous H, Tibbitts T, Bakios J et al. Oral immunization with recombinant urease combined with antimicrobial therapy augment clearance of an H. felis infection in mice. Gut 1996; 39 (Suppl 2): A75
36. Kreiss C, Buclin T, Cosma M, Courthésy-Theulaz I, Michetti P. Safety of oral immunization with recombinant urease in patients with Helicobacter pylori infection. Lancet 1996; 347: 1630-1
37. Scott DA, Baqar S, Oplinger M et al. Safety and adjuvant activity of native and mutant E. coli heat-labile toxins. Symposium Proceedings: Progress on modulation of the immune response to vaccine antigens. International Association of Biological Standards Task Force on Vaccines, World Health Organization. June 18-21, 1996, University of Bergen, Norway